FTC weighs in on “no-authorised-generic” antitrust case

07-05-2014

FTC weighs in on “no-authorised-generic” antitrust case

Photo: Cvandyke / Shutterstock.com

The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK).


FTC, antitrust, FTC v Actavis, “no-authorised-generic”, US Court of Appeals for the Third Circuit

LSIPR